B. Lemaitre, E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann, The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults, Cell, vol.86, pp.973-983, 1996.

S. Akira and K. Takeda, Toll-like receptor signalling, Nat. Rev. Immunol, vol.4, pp.499-511, 2004.

B. Beutler, K. Hoebe, X. Du, and R. J. Ulevitch, How we detect microbes and respond to them: the Toll-like receptors and their transducers, J. Leukocyte Biol, vol.74, pp.479-485, 2003.

A. Poltorak, X. He, I. Smirnova, M. Y. Liu, C. Van-huffel et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998.

H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato et al., A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000.

L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3, Nature, vol.413, pp.732-738, 2001.

F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning et al., Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8, Science, vol.303, pp.1526-1529, 2004.

L. A. O'neill, How Toll-like receptors signal: what we know and what we don't know, Curr. Opin. Immunol, vol.18, pp.3-9, 2006.

K. Takeda and S. Akira, TLR signaling pathways, Semin. Immunol, vol.16, pp.3-9, 2004.

H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya, TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-? induction, Nat. Immunol, vol.4, pp.161-167, 2003.

M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho et al., Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway, Science, vol.301, pp.640-643, 2003.

M. Muzio, D. Bosisio, N. Polentarutti, G. D'amico, A. Stoppacciaro et al., Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells, J. Immunol, vol.164, pp.5998-6004, 2000.

N. Kadowaki, S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein et al., Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens, J. Exp. Med, vol.194, pp.863-869, 2001.

C. Reis-e-sousa, Toll-like receptors and dendritic cells: for whom the bug tolls, Semin. Immunol, vol.16, pp.27-34, 2004.

J. R. Ramirez-pineda, A. Frohlich, C. Berberich, and H. Moll, Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC, J. Immunol, vol.172, pp.6281-6289, 2004.

T. Kaisho and S. Akira, Regulation of dendritic cell function through Toll-like receptors, Curr. Mol. Med, vol.3, pp.373-385, 2003.

M. Komai-koma, L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew, TLR2 is expressed on activated T cells as a costimulatory receptor, Proc. Natl. Acad. Sci. USA, vol.101, pp.3029-3034, 2004.

R. P. Sutmuller, M. H. Brok, M. Kramer, E. J. Bennink, L. W. Toonen et al., Toll-like receptor 2 controls expansion and function of regulatory T cells, J. Clin. Invest, vol.116, pp.485-494, 2006.

G. Caron, D. Duluc, I. Fremaux, P. Jeannin, C. David et al., Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-? production by memory CD4 ? T cells, J. Immunol, vol.175, pp.1551-1557, 2005.

N. K. Crellin, R. V. Garcia, O. Hadisfar, S. E. Allan, T. S. Steiner et al., Human CD4 ? T cells express TLR5 and its ligand flagellin, 2005.

, J. Immunol, vol.175, pp.8051-8059

G. Peng, Z. Guo, Y. Kiniwa, K. S. Voo, W. Peng et al., Toll-like receptor 8-mediated reversal of CD4 ? regulatory T cell function, Science, vol.309, pp.1380-1384, 2005.

A. E. Gelman, J. Zhang, Y. Choi, and L. A. Turka, Toll-like receptor ligands directly promote activated CD4 ? T cell survival, J. Immunol, vol.172, pp.6065-6073, 2004.

V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer et al., Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J. Immunol, vol.168, pp.4531-4537, 2002.

K. A. Zarember and P. J. Godowski, Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines, J. Immunol, vol.168, pp.554-561, 2002.

V. Sobek, N. Birkner, I. Falk, A. Wurch, C. J. Kirschning et al., Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease, Arthritis Res. Ther, vol.6, pp.433-446, 2004.

A. Zippelius, P. Batard, V. Rubio-godoy, G. Bioley, D. Lienard et al., Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance, Cancer Res, vol.64, pp.2865-2873, 2004.

P. Romero, J. C. Cerottini, and D. E. Speiser, Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptidebased vaccination, Cancer Immunol. Immunother, vol.53, pp.249-255, 2004.

D. E. Speiser, D. Lienard, N. Rufer, V. Rubio-godoy, D. Rimoldi et al., Rapid and strong human CD8 ? T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909, J. Clin. Invest, vol.115, pp.739-746, 2005.

N. Chaput, N. E. Schartz, F. Andre, J. Taieb, S. Novault et al., Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection, J. Immunol, vol.172, pp.2137-2146, 2004.

O. Schulz, S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte et al., Toll-like receptor 3 promotes cross-priming to virus-infected cells, Nature, vol.433, pp.887-892, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00165709

Z. Cui and F. Qiu, Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model, Cancer Immunol. Immunother, vol.55, pp.1267-1279, 2006.

M. L. Salem, A. N. Kadima, D. J. Cole, and W. E. Gillanders, Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity, J. Immunother, vol.28, pp.220-228, 2005.

N. Rufer, A. Zippelius, P. Batard, M. J. Pittet, I. Kurth et al., Ex vivo characterization of human CD8 ? T subsets with distinct replicative history and partial effector functions, Blood, vol.102, pp.1779-1787, 2003.

D. Wesch, S. Beetz, H. H. Oberg, M. Marget, K. Krengel et al., Direct costimulatory effect of TLR3 ligand poly(I:C) on human ?? T lymphocytes, J. Immunol, vol.176, pp.1348-1354, 2006.

D. H. Raulet, Roles of the NKG2D immunoreceptor and its ligands, Nat. Rev. Immunol, vol.3, pp.781-790, 2003.

S. Bauer, V. Groh, J. Wu, A. Steinle, J. H. Phillips et al., Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA, Science, vol.285, pp.727-729, 1999.

V. Groh, R. Rhinehart, J. Randolph-habecker, M. S. Topp, S. R. Riddell et al., Costimulation of CD8?? T cells by NKG2D via engagement by MIC induced on virus-infected cells, Nat. Immunol, vol.2, pp.255-260, 2001.

A. Diefenbach, E. R. Jensen, A. M. Jamieson, and D. H. Raulet, Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity, Nature, vol.413, pp.165-171, 2001.

K. N. Schmidt, B. Leung, M. Kwong, K. A. Zarember, S. Satyal et al., APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA, J. Immunol, vol.172, pp.138-143, 2004.

S. Sivori, M. Falco, M. Della-chiesa, S. Carlomagno, M. Vitale et al., CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells, Proc. Natl. Acad. Sci. USA, vol.101, pp.10116-10121, 2004.

D. A. Chesler and C. S. Reiss, The role of IFN-? in immune responses to viral infections of the central nervous system, Cytokine Growth Factor Rev, vol.13, pp.441-454, 2002.

L. Malmgaard, Induction and regulation of IFNs during viral infections, J. Interferon Cytokine Res, vol.24, pp.439-454, 2004.

M. Lohoff, D. Ferrick, H. W. Mittrucker, G. S. Duncan, S. Bischof et al., Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo, Immunity, vol.6, pp.681-689, 1997.

M. Lohoff and T. W. Mak, Roles of interferon-regulatory factors in Thelper-cell differentiation, Nat. Rev. Immunol, vol.5, pp.125-135, 2005.

N. Harii, C. J. Lewis, V. Vasko, K. Mccall, U. Benavides-peralta et al., Thyrocytes express a functional Toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis, Mol. Endocrinol, vol.19, pp.1231-1250, 2005.

S. Doyle, S. Vaidya, R. O'connell, H. Dadgostar, P. Dempsey et al., IRF3 mediates a TLR3/ TLR4-specific antiviral gene program, Immunity, vol.17, pp.251-263, 2002.

M. Matsumoto, K. Funami, M. Tanabe, H. Oshiumi, M. Shingai et al., Subcellular localization of Toll-like receptor 3 in human dendritic cells, J. Immunol, vol.171, pp.3154-3162, 2003.

O. De-bouteiller, E. Merck, U. A. Hasan, S. Hubac, B. Benguigui et al., Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH, J. Biol. Chem, vol.280, pp.38133-38145, 2005.

T. Seya, T. Akazawa, J. Uehori, M. Matsumoto, I. Azuma et al., Role of Toll-like receptors and their adaptors in adjuvant immunotherapy for cancer, Anticancer Res, vol.23, pp.4369-4376, 2003.

D. Van-duin, R. Medzhitov, and A. C. Shaw, Triggering TLR signaling in vaccination, Trends Immunol, vol.27, pp.49-55, 2006.

E. S. Hoffman, R. E. Smith, R. C. Renaud, and J. , From the analyst's couch: TLR-targeted therapeutics, Nat. Rev. Drug Discov, vol.4, pp.879-880, 2005.